Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02150109 · ClinicalTrials.gov registry record · NA
Evaluation of an Karajishi Contour Investigational Blood Glucose Monitoring System (ISO/FDA Study)
A NA study, sponsored by Ascensia Diabetes Care.
- Completed
- Registry status
- NA
- Development phase
- 372
- Enrollment target
NCT02150109 is a NA study that has completed, run by Ascensia Diabetes Care. The registered enrollment target is 372 participants.
The verdict
NCT02150109, a NA study, has completed, sponsored by Ascensia Diabetes Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 372 participants
- Enrollment target
Study Summary
The purpose of this study was to determine if untrained persons with diabetes and without diabetes could operate the Investigational Blood Glucose Monitoring System (BGMS) and obtain valid blood glucose results.
Interventions
- DEVICE Subjects WITH/WITHOUT Diabetes Use Karajishi Contour BGMS
- DEVICE Subjects WITH Diabetes Use Karajishi Contour BGMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 372 participants |
| Start Date | 2014-06 |
| Est. Completion | 2014-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02150109
The ClinicalTrials.gov registry entry for NCT02150109 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 372 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ascensia Diabetes Care, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Subjects WITH/WITHOUT Diabetes Use Karajishi Contour BGMS is the first listed.
NCT02150109 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02150109 about?
NCT02150109 is a clinical study titled "Evaluation of an Karajishi Contour Investigational Blood Glucose Monitoring System (ISO/FDA Study)". The purpose of this study was to determine if untrained persons with diabetes and without diabetes could operate the Investigational Blood Glucose Monitoring System (BGMS) and obtain valid blood glucose results.
What is the current status of trial NCT02150109?
This trial is currently completed. It is a NA study. The enrollment target is 372 participants. The study started on 2014-06. Estimated completion is 2014-06.
What interventions are being tested in trial NCT02150109?
The interventions under investigation include: Subjects WITH/WITHOUT Diabetes Use Karajishi Contour BGMS (DEVICE), Subjects WITH Diabetes Use Karajishi Contour BGMS (DEVICE).
Who is sponsoring clinical trial NCT02150109?
This trial is sponsored by Ascensia Diabetes Care, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.